Sorting nexin 8 (SNX8) has emerged as a potential therapeutic target for NAFLD because it directly binds to FASN and boosts FASN degradation by facilitating the tripartite motif-containing 28 (TRIM28)-FASN interaction [65]. The gene discussed is SNX8; the disease is metabolic dysfunction-associated steatotic liver disease.